Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
In addition to Sanofi, firms recalling OTC ranitidine products with documentation included in FDA's database updates through 9 January are Amneal Pharmaceuticals, Preferred Pharmaceuticals, which distributed products made by Amneal, and Granules India Ltd.
Sanofi's recall of OTC Zantac due to contamination of the active ingredient ranitidine with a potential carcinogenic is so widespread the US Food and Drug Administration's documentation of the firm's actions doesn't identify quantities of containers or packages but refers only to "all lots" of the products.
Information on some other firms' recalls for private label and store brand copies of OTC Zantac in 75- and 150-mg ranitidine formulations added to the FDA's recalls database between mid-December and 8 January also doesn't include amounts, which the agency's typically does in its recall records. Rather than identify all lots as the products covered in the recalls, the firms' information includes lists of dozens of serial numbers and other identifying data.
In addition to Sanofi, firms recalling OTC ranitidine products with documentation included in the FDA's database updates for 11, 18 and 25 December and 2 and 8 January are Amneal Pharmaceuticals Inc, Preferred Pharmaceuticals Inc., which distributed products made by Amneal, and Granules India Ltd. (See table linked below.)
Ranitidine contamination and the FDA's response to the problem prompted Rep. Rosa DeLauro, D-CT, to ask that it keep the ingredient off the market and to re-introduced legislation proposing that the agency have mandatory recall authority for drugs.
HBW Insight: Health, Beauty and Wellness
By Ryan Nelson 16 Jul 2020
Uncertainties related to leave-on cosmetics’ microplastic releases to the environment, and the costs industry would face in removing microplastic from...
HBW Insight: Health, Beauty and Wellness
By Tom Gallen
Coronavirus pandemic drove up sales of vitamin C supplements and other immunity boosters in Italy in the opening three months of the year.
Topics Coronavirus $name
HBW Insight: Health, Beauty and Wellness
By David Ridley
UK's NICE reviews whether Vitamin D can prevent or treat COVID-19, finds evidence wanting.
Topics Coronavirus $name
Request a Trial
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Biomedtracker provides real-time analysis of major market-moving events in the pharma and biotech industries. With catalyst tracking and expert insights, Biomedtracker helps you stay on top of breaking events, the drugs pipeline, upcoming milestones, companies, and deals – and their impact on the markets you care about.
Understand what’s happening in the market right now and what it means for the future of your business with news and insight from our team of journalists and analysts. Scrip is essential for anyone making commercial decisions in the pharmaceutical industry.
Biomedtracker, Strategic Transactions, and Medtrack have been combined into a single commercial intelligence solution, enabling you to make the most informed decisions to develop successful commercial strategies. Track and understand the impacts of market events for the companies, diseases, products, and targets you care about.
Looking for more products Product Finder
